type 2 diabetes
Troglitazone is a new thiazolidinedione oral antidiabetic agent approved for use        to improve glycaemic control in patients with type 2 diabetes.
Troglitazone is a new thiazolidinedione oral antidiabetic agent approved for use        to improve glycaemic control in  @OBJECT$   @PREDICAT$   @SUBJECT$ .